Fighting with the COVID-19, Microprofit stands with you.
From Dec.2019 to recent days, the coronavirus disease 2019 (COVID-19) have been spreading all over the world. Under the strict control of quarantine and transmission, the outburst of COVID-19 in mainland China is already under control. Yet the transmission and growth of infected case is still increasing worldwide.Confronting the severe situation especially in Europe and Middle East, Microprofit Biotech has dedicated to the research and development of the test kits for the SARS-CoV-2. For the very first products, we are going to launch the fluorecare® SARS-CoV-2 IgG and IgM Antibody Combined Test Kit (Colloidal Gold Chromatographic Immunoassay). The kit is able to detect the present of certain antibodies in human body generated in resistance to the invasion of 2019-nCoV. Application of our test kit provides you the rapid and on-site screening.
In addition, we have scheduled six test kits for the detection of SARS-CoV-2 as followed:
SARS-CoV-2 Antibody Test Kit (Colloidal Gold Chromatographic Immunoassay)
SARS-CoV-2 Spike Protein Test Kit (Colloidal Gold Chromatographic Immunoassay)
SARS-CoV-2 IgG and IgM Antibody Combined Test Kit (Colloidal Gold Chromatographic Immunoassay)
SARS-CoV-2 Antibody Test Kit (Fluorescence Immunoassay)
SARS-CoV-2 Spike Protein Test Kit (Fluorescence Immunoassay)
SARS-CoV-2 IgG and IgM Antibody Combined Test Kit (Fluorescence Immunoassay). The rest of test kit will be launched soon.
Fighting with the COVID-19, Microprofit stands with you.
